
浏览全部资源
扫码关注微信
1.广西中医药大学赛恩斯新医药学院,南宁 530222
2.广西中医药大学第一附属医院肾内科,南宁 530023
副主任医师,硕士。研究方向:中西医结合(肾病方向)。E-mail:535386637@qq.com
主任医师,博士。研究方向:肾内科。E-mail:zhongjian@medmail.com
收稿:2026-02-05,
修回:2026-06-23,
录用:2026-06-24,
纸质出版:2026-07-15
移动端阅览
黎凤仪,钟建.益肾通络方改善高糖诱导的肾小管上皮细胞损伤及其对SIRT3-AMPK/PGC-1α/CPT1A通路的影响[J].中国药房,2026,37(13):1710-1715.
LI Fengyi,ZHONG Jian.Effects of Yishen tongluo formula on high glucose-induced injury in renal tubular epithelial cells and its impact on the SIRT3-AMPK/PGC-1α/CPT1A pathway[J].ZHONGGUO YAOFANG,2026,37(13):1710-1715.
黎凤仪,钟建.益肾通络方改善高糖诱导的肾小管上皮细胞损伤及其对SIRT3-AMPK/PGC-1α/CPT1A通路的影响[J].中国药房,2026,37(13):1710-1715. DOI: 10.6039/j.issn.1001-0408.2026.13.09.
LI Fengyi,ZHONG Jian.Effects of Yishen tongluo formula on high glucose-induced injury in renal tubular epithelial cells and its impact on the SIRT3-AMPK/PGC-1α/CPT1A pathway[J].ZHONGGUO YAOFANG,2026,37(13):1710-1715. DOI: 10.6039/j.issn.1001-0408.2026.13.09.
目的
2
探讨益肾通络方对高糖诱导的肾小管上皮细胞损伤的改善作用及其对沉默信息调节因子3(SIRT3)-腺苷一磷酸活化蛋白激酶(AMPK)/过氧化物酶体增殖物激活受体γ共激活因子1α(PGC-1α)/肉碱棕榈酰基转移酶1A(CPT1A)信号通路的影响。
方法
2
以人肾小管上皮细胞HK-2为对象,将其分为正常糖组(NC组)、高糖组(HG组)、高糖+益肾通络方低剂量组[HG+L组,0.5 mg/mL(以总生药量计)]、高糖+益肾通络方高剂量组[HG+H组,1.0 mg/mL(以总生药量计)]。除NC组外,其余各组细胞均在高糖(30 mmol/L)条件下培养,HG+L、HG+H组细胞同时接受相应质量浓度药液干预。检测各组细胞培养0、24、48 h时的细胞活力,以及培养48 h后的活性氧(ROS)水平、腺苷三磷酸(ATP)含量和SIRT3-AMPK/PGC-1α/CPT1A信号通路相关分子的表达情况。
结果
2
与NC组比较,HG组细胞活力(培养24、48 h)及ATP含量均显著降低,ROS水平显著升高(
P
<0.05);SIRT3、PGC-1α、CPT1A蛋白表达,PGC-1α、CPT1A mRNA表达,以及AMPK蛋白磷酸化水平均显著下调或降低(
P
<0.05)。与HG组比较,HG+L、HG+H组细胞上述指标均显著改善,且HG+H组的改善更为明显(
P
<0.05)。
结论
2
益肾通络方可改善高糖诱导的肾小管上皮细胞损伤,其作用可能与激活SIRT3-AMPK/PGC-1α/CPT1A信号通路、改善线粒体能量代谢、减轻氧化应激有关。
OBJECTIVE
2
To investigate the protective effect of Yishen tongluo formula on high glucose-induced injury in renal tubular epithelial cells and its impact on the silence information regulator 3 (SIRT3)-adenosine monophosphate-activated protein kinase (AMPK)/peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α)/carnitine palmitoyltransferase 1A (CPT1A) signaling pathway.
METHODS
2
Human renal tubular epithelial cells HK-2 were used as the subject. The cells were divided into a normal glucose group (NC group), a high glucose group (HG group), a high glucose+low-dose Yishen tongluo formula group [HG+L group, 0.5 mg/mL (calculated by crude drugs)], and a high glucose+high-dose Yishen tongluo formula group [HG+H group, 1.0 mg/mL (calculated by crude drugs)]. Except for the NC group, cells in all other groups were cultured under high glucose conditions (30 mmol/L), and cells in the HG+L and HG+H groups were simultaneously treated with the corresponding mass concentrations of medicinal liquid. Cell viability was assessed at 0, 24, and 48 h post-incubation, and reactive oxygen species (ROS) level, adenosine triphosphate (ATP) content, and the expression of molecules related to the SIRT3-AMPK/PGC-1α/CPT1A signaling pathway were measured after 48 h of incubation.
RESULTS
2
Compared with the NC group, the HG group showed significantly reduced cell viabilities (at 24 and 48 h) and ATP content, along with significantly elevated ROS levels (
P
<0.05). Additionally, the protein expressions of SIRT3, PGC-1α and CPT1A, as well as the mRNA expressions of PGC-1α and CPT1A, and the phosphorylation level of AMPK protein were all significantly downregulated or decreased(
P
<0.05). Compared with the HG group, the aforementioned indicators were significantly improved in both HG+L and HG+H groups, with the improvement being more pronounced in the HG+H group (
P
<0.05).
CONCLUSIONS
2
The Yishen tongluo formula can improve high-glucose-induced damage to renal tubular epithelial cells; its action may be related to activating the SIRT3-AMPK/PGC-1α/CPT1A signaling pathway, improving mitochondrial energy metabolism, and alleviating oxidative stress.
Yang S Q , Wang X Y , Zhang Y , et al . SIRT3 regulates CPT1a acetylation and fatty acid oxidation in renal tubular epithelial cells under diabetic condition [J ] . Mol Biol Rep , 2025 , 52 ( 1 ): 603 .
Clark A J , Parikh S M . Targeting energy pathways in kidney disease:the roles of sirtuins,AMPK,and PGC1α [J ] . Kidney Int , 2021 , 99 ( 4 ): 828 - 840 .
Juszczak F , Caron N , Mathew A V , et al . Critical role for AMPK in metabolic disease-induced chronic kidney disease [J ] . Int J Mol Sci , 2020 , 21 ( 21 ): 7994 .
朱清 , 王学艺 , 韩佳瑞 , 等 . 中药干预糖尿病肾病肾小管损伤的研究进展 [J ] . 中国医药 , 2023 , 18 ( 5 ): 787 - 792 .
陈金虎 , 倪利华 , 廖泽锦 , 等 . 沉默信息调节因子3在高糖诱导的肾小管上皮细胞铁死亡中的作用 [J ] . 中华肾脏病杂志 , 2024 , 40 ( 7 ): 540 - 552 .
Wan L , Qian Y C , Ni W J , et al . Linagliptin improves diabetic kidney disease in rats by promoting mitochondrial biogenesis through the AMPK/PGC-1 α /TFAM pathway [J ] . Journal of Southern Medical University , 2023 , 43 ( 12 ): 2053 - 2060 .
马学虎 , 冀思同 , 曹佩佩 , 等 . 沉默信息调节因子2相关酶3通过提升线粒体功能改善奶牛乳腺氧化应激和炎性反应 [J ] . 动物营养学报 , 2024 , 36 ( 12 ): 8049 - 8061 .
申学婷 , 张双双 , 陈小燕 , 等 . 电针“天枢”穴结合二甲双胍对2型糖尿病大鼠糖脂水平的影响 [J ] . 中华中医药杂志 , 2023 , 38 ( 1 ): 111 - 116 .
Qin Z , Zhou S Y , Chang X , et al . SIRT3 regulates mitochondrial function:a promising star target for cardiovascular disease therapy [J ] . Biomed Pharmacother , 2024 , 170 : 116004 .
Sun M Y , Ye H J , Zheng C , et al . Astragalin ameliorates renal injury in diabetic mice by modulating mitochondrial quality control via AMPK-dependent PGC1α pathway [J ] . Acta Pharmacol Sin , 2023 , 44 ( 8 ): 1676 - 1686 .
Ma Z Y , Huang X N , Kuang J Q , et al . Cpt1a drives primed-to-naive pluripotency transition through lipid remodeling [J ] . Commun Biol , 2024 , 7 ( 1 ): 1223 .
Sharma A , Anand S K , Singh N , et al . AMP-activated protein kinase:an energy sensor and survival mechanism in the reinstatement of metabolic homeostasis [J ] . Exp Cell Res , 2023 , 428 ( 1 ): 113614 .
Brownlee M . The pathobiology of diabetic complications:a unifying mechanism [J ] . Diabetes , 2005 , 54 ( 6 ): 1615 - 1625 .
王爽 , 徐恩爽 , 范玉营 , 等 . 基于AMPK-PGC-1α通路探究阿司匹林对顺铂致急性肾损伤小鼠保护机制研究 [C ] // 中国畜牧兽医学会兽医外科学分会第十届二次理事会暨第25次学术研讨会 , 2021 : 225 - 226 .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621